Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DUBLIN, Ireland, Aug. 7, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, announced that Gene Kinney, PhD, the Company’s Chief Scientific Officer and Head of Research and Development, will be presenting at the Wedbush Securities Life Sciences Management Access Conference on Wednesday, August 14, 2013, at 10:20 AM ET. The conference will be held at the Le Parker Meridien in New York.
Help employers find you! Check out all the jobs and post your resume.
